Affiliation:
1. the Affiliated Huai'an Hospital of Xuzhou Medical University
Abstract
Abstract
Objective: The purpose of this trial was to clinically assess the effects of endodontic treatment on glycemic control in patients with type 2 diabetes mellitus (T2DM) and apical periodontitis (AP). Methodology: For present trial, AP+T2DM with patients insulin injection (n=65), AP +T2DM patients with hypoglycaemic agents (n=82), and AP patients without DM (n=86) were enrolled. After demographic characteristics and clinical examination were achieved, root canal treatment (RCT) was performed for each patients. Subjects were followed up at 2-week, 3- and 6-month. At each visit, blood samples were taken, clinical laboratory studies were performed. At 6-month follow-up, Periapical Index (PAI) score was used to assessed the periapical status.Results: A total of 237 subjects who meet the including criteria were allocated in 3 groups and 223 subjects (94.1%) completed cthe treatment and the follow-up assessments. After treatment, taking PAI into consideration, both groups showed significant improvement of AP in each group (P<0.05). Patients had a continued significant lower concentration of fasting plasma glucose (FPG) levels at follow-up except for G1 and G2 (P<0.05). A continued reduction of hemoglobin glycation (HbA1c) was observed in most of time points (P<0.05). Throughout the trial, there are also significant changes of laboratory tests of inflammatory factors in short-term.Conclusion: Endodontic therapy improved AP healing, glycemic control and systemic inflammation in patients with T2DM and/or AP in each group. However, a continued reduction in inflammatory factors and decreasing of HbA1c in short-term did not be observed in this trial.
Publisher
Research Square Platform LLC
Reference41 articles.
1. Shepherd PR,Kahn BB (1999) Glucose transporters and insulin action–implications for insulin resistance and diabetes mellitus. The New England Journal of Medicine:248 – 57
2. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications;Zheng Y;Nat Rev Endocrinol,2017
3. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021;Tion ADA;Diabetes Care,2021
4. Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia:3–19
5. Mechanisms of disease:Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes;Muoio DM;Nat Rev Mol Cell Biol,2008